BAFNA PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Bafna Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-2.54₹ -3.05
As on Feb 5, 2026, 4:01 PM IST
Bafna Pharmaceuticals Price Performance
Today's LowToday's High
₹116.85₹116.85
₹116.85
52 Weeks' Low52 Weeks' High
₹67.80₹204.95
₹116.85
Open Price
₹116.85
Prev. Close
₹119.90
Volume
10
Over the last 5 years, the share price of Bafna Pharmaceuticals has declined 0.36% CAGR. Over the past year, the corresponding return has been 49.14%.
Bafna Pharmaceuticals’s current P/E of -11.18x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Bafna Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Bafna Pharmaceuticals | -1.23 | -24.42 | -34.63 | 36.78 | 49.14 | 5.52 | -0.36 |
| Sun Pharmaceutical Industries | 6.21 | -3.76 | 0.49 | 6.27 | -2.78 | 18.29 | 21.70 |
| Divi's Laboratories | -0.45 | -9.29 | -12.48 | -1.75 | -1.47 | 29.45 | 9.77 |
| Torrent Pharmaceuticals | -0.71 | -0.13 | 10.61 | 11.51 | 24.37 | 36.68 | 23.31 |
| Cipla | 0.52 | -13.04 | -11.28 | -10.51 | -9.57 | 8.92 | 9.44 |
| Dr. Reddy's Laboratories | 1.87 | -1.18 | 3.00 | 3.68 | 0.41 | 12.57 | 5.02 |
| Lupin | 0.80 | 0.76 | 10.85 | 17.11 | -0.81 | 42.77 | 15.18 |
| Zydus Lifesciences | -0.02 | -4.97 | -5.47 | -5.14 | -12.23 | 23.47 | 13.33 |
| Mankind Pharma | -3.29 | -8.33 | -11.01 | -19.51 | -17.11 | 13.00 | 7.61 |
| Aurobindo Pharma | -1.43 | -2.98 | 4.77 | 11.39 | 0.29 | 42.22 | 4.54 |
| Alkem Laboratories | -0.17 | 0.20 | 0.35 | 16.16 | 7.74 | 22.65 | 14.31 |
| Biocon | -0.37 | -5.16 | -5.14 | 1.28 | -7.98 | 14.84 | -2.24 |
| Abbott India | -0.93 | -3.56 | -6.99 | -15.93 | -5.79 | 9.50 | 13.59 |
| Glenmark Pharmaceuticals | -4.34 | -6.99 | 6.56 | -4.69 | 28.78 | 69.07 | 30.84 |
| Laurus Labs | -1.50 | -14.81 | -2.90 | 13.78 | 49.41 | 41.70 | 21.64 |
| GlaxoSmithKline Pharmaceuticals | 3.69 | 0.15 | -4.49 | -8.33 | 9.69 | 26.14 | 11.25 |
| Anthem Biosciences | 9.15 | 1.73 | -6.20 | -9.62 | -10.55 | -3.65 | -2.21 |
| Ipca Laboratories | -3.95 | -3.95 | 8.36 | 1.83 | -6.90 | 18.01 | 7.76 |
| Ajanta Pharma | 2.01 | -0.25 | 10.57 | 11.71 | 5.23 | 34.62 | 18.68 |
| Gland Pharma | -0.07 | 8.66 | -2.86 | -5.66 | 21.42 | 16.24 | -4.50 |
Over the last one year, Bafna Pharmaceuticals has gained 49.14% compared to peers like Sun Pharmaceutical Industries (-2.78%), Divi's Laboratories (-1.47%), Torrent Pharmaceuticals (24.37%). From a 5 year perspective, Bafna Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (21.70%) and Divi's Laboratories (9.77%).
Bafna Pharmaceuticals Financials
Bafna Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 118.98 | 119.64 |
| 10 | 117.95 | 121.05 |
| 20 | 127.76 | 127.17 |
| 50 | 144.15 | 137.8 |
| 100 | 143.77 | 135.22 |
| 200 | 112.59 | 121.81 |
Bafna Pharmaceuticals Share Holding Pattern
In the latest quarter, Bafna Pharmaceuticals remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 9.34%, and public shareholding unchanged at 15.66% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Bafna Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Feb 05, 2026, 8:42 PM IST | Bafna Pharma. - Board Meeting Intimation for Meeting Scheduled On February 11, 2026 |
| Jan 24, 2026, 12:33 AM IST | Bafna Pharmaceutical - Announcement under Regulation 30 (LODR)-Credit Rating |
| Jan 09, 2026, 8:52 PM IST | Bafna Pharmaceutical - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Nov 11, 2025, 11:03 PM IST | Bafna Pharmaceutical - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025 |
| Nov 11, 2025, 10:52 PM IST | Bafna Pharmaceutical - Board Meeting Outcome for Outcome For The Board Meeting Held On 11/11/2025 |
About Bafna Pharmaceuticals
Bafna Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 28/03/1995 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L24294TN1995PLC030698 and registration number is 030698. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 145.86 Cr. and Equity Capital is Rs. 23.66 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressBafna Towers, Chennai (Madras) Tamil Nadu 600001
- Contact
Management
- Mrs. S HemalathaWhole Time Director
- Mr. Vinayak Dinesh DendukuriWhole Time Director
- Mr. Upendar Mekala ReddyNon Exe.Non Ind.Director
- Mrs. Akila C RajuNon Exe.Non Ind.Director
- Ms. R ChitraInd. Non-Executive Director
- Mr. Navin KumarInd. Non-Executive Director
FAQs on Bafna Pharmaceuticals Share Price
What is the share price of Bafna Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Bafna Pharmaceuticals is ₹116.85 as on Feb 05, 2026.
What kind of stock is Bafna Pharmaceuticals?
The Bafna Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Bafna Pharmaceuticals?
The market cap of Bafna Pharmaceuticals is ₹276.42 Cr as on Feb 05, 2026.
What are today's High and Low prices of Bafna Pharmaceuticals?
Today’s highest and lowest price of Bafna Pharmaceuticals are ₹116.85 and ₹116.85.
What are the 52 Week High and 52 Week Low of Bafna Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Bafna Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Bafna Pharmaceuticals is ₹204.95 and 52-week low of Bafna Pharmaceuticals is ₹67.80 as on Feb 05, 2026.
How has the Bafna Pharmaceuticals performed historically in terms of returns?
The Bafna Pharmaceuticals has shown returns of -2.54% over the past day, -24.42% for the past month, -34.63% over 3 months, 49.14% over 1 year, 5.52% across 3 years, and -0.36% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Bafna Pharmaceuticals?
P/E ratio of and PB ratio of Bafna Pharmaceuticals are -11.18 and 16.21 on Feb 05, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse